Stifel eleva preço-alvo das ações da Xenon Pharmaceuticals para US$ 66 devido ao potencial do XEN1101
Xenon Pharmaceuticals Inc. (XENE) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:XENE) 2026-01-12